Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

STATSAUTORISERET FODTERAPEUT BIRGIT AALBÆK CHRISTIANSEN ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   0.8% 0.8% 0.8% 0.8% 0.8% 0.8% 0.8% 0.8%   Bankruptcy risk   2.4% 3.9% 3.5% 5.2% 3.7% 3.5% 17.2% 17.0%   Credit score (0-100)   65 52 53 41 51 52 9 10   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   592 523 429 329 498 451 0.0 0.0   EBITDA   75.9 -32.7 -39.6 -80.1 95.7 65.4 0.0 0.0   EBIT   63.5 -43.4 -47.0 -87.0 89.0 60.8 0.0 0.0   Pre-tax profit (PTP)   60.5 20.4 -51.2 -96.1 98.0 49.6 0.0 0.0   Net earnings   57.5 15.1 -40.1 -57.3 76.4 38.1 0.0 0.0   Pre-tax profit without non-rec. items   60.5 20.4 -51.2 -96.1 98.0 49.6 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   51.7 41.0 33.7 26.9 20.2 15.6 0.0 0.0   Shareholders equity total   226 241 201 246 322 360 235 235   Interest-bearing liabilities   105 72.0 89.2 11.8 11.8 14.9 0.0 0.0   Balance sheet total (assets)   359 372 343 274 356 400 235 235   Net Debt   -66.6 -134 -71.0 -77.4 -173 -212 -235 -235     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   592 523 429 329 498 451 0.0 0.0   Gross profit growth   16.0% -11.7% -17.9% -23.4% 51.6% -9.4% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   359 372 343 274 356 400 235 235   Balance sheet change%   23.8% 3.6% -7.8% -20.2% 29.8% 12.4% -41.2% 0.0%   Added value   75.9 -32.7 -39.6 -80.1 95.8 65.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -25 -21 -15 -14 -13 -9 -16 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 -1.0 -2.0 -3.0 1.0 2.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   10.7% -8.3% -10.9% -26.5% 17.9% 13.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   19.6% 7.0% -13.1% -28.2% 31.6% 16.1% 0.0% 0.0%   ROI %   21.3% 7.9% -15.6% -31.8% 33.7% 17.2% 0.0% 0.0%   ROE %   29.2% 6.5% -18.2% -25.7% 26.9% 11.2% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   63.0% 64.7% 58.5% 89.6% 90.5% 90.1% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -87.7% 409.1% 179.2% 96.6% -180.8% -324.1% 0.0% 0.0%   Gearing %   46.6% 29.9% 44.5% 4.8% 3.7% 4.1% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   2.9% 5.9% 5.3% 18.1% 13.0% 83.5% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   1.5 1.7 1.4 5.1 6.6 6.7 0.0 0.0   Current Ratio   1.9 2.1 1.8 6.8 8.3 8.2 0.0 0.0   Cash and cash equivalent   171.8 205.9 160.2 89.2 184.8 226.8 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   124.5 148.7 115.9 150.9 220.5 268.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   76 -33 -40 -80 96 65 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   76 -33 -40 -80 96 65 0 0   EBIT / employee   63 -43 -47 -87 89 61 0 0   Net earnings / employee   58 15 -40 -57 76 38 0 0